TALIS BIOMEDICAL CORP (TLIS)
US87424L2079 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -62.01M | -113.01M | -192.04M | -91.13M | -27.47M | |||
| Depreciation Amortization | 770.00K | 8.83M | 1.58M | 760.00K | 730.00K | |||
| Change In Working Capital | -3.42M | -7.69M | 8.82M | -950.00K | 640.00K | |||
| Other non cash items | 11.42M | 11.73M | 10.25M | 4.29M | 1.78M | |||
| OPERATING CASH FLOW | -53.24M | -100.14M | -171.38M | -87.02M | -24.33M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -486.00K | -1.62M | -2.87M | -8.20M | -580.00K | |||
| INVESTING CASH FLOW | -486.00K | -1.62M | -2.87M | -8.20M | -580.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 15.00M | |||
| Stock Issued/Repurchased | 33.00K | 410.00K | 234.43M | 248.21M | 24.61M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -1.45M | N/A | |||
| FINANCING CASH FLOW | 33.00K | 410.00K | 234.43M | 246.75M | 39.61M | |||
| CHANGE IN CASH | -53.69M | -101.35M | 60.18M | 151.53M | 14.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -53.24M | -100.14M | -171.38M | -87.02M | -24.33M | |||
| Capital Expenditure | -486.00K | -1.62M | -2.87M | -8.20M | -580.00K | |||
| FREE CASH FLOW | -53.73M | -101.76M | -174.25M | -95.22M | -24.91M | |||
All data in USD